Helen Stephens Group’s AbbVie ABBV Stock Holding History

Helen Stephens Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$366K	Buy	1,456 +41	+3%	+$8.82K	0.06%	102
2026 Q1	$308K	Sell	1,415 -456	-24%	-$101K	0.06%	95
2025 Q4	$427K	Sell	1,871 -236	-11%	-$53.8K	0.09%	75
2025 Q3	$488K	Buy	2,107 +791	+60%	+$161K	0.11%	66
2025 Q2	$244K	Sell	1,316 -10	-0.8%	-$1.86K	0.06%	80
2025 Q1	$278K	Sell	1,326 -43	-3%	-$8.36K	0.08%	70
2024 Q4	$243K	Buy	1,369 +61	+5%	+$11.2K	0.07%	77
2024 Q3	$258K	Buy	+1,308	New	+$244K	0.08%	76

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Helen Stephens Group's ABBV Position: Q2 2026 in Review

Helen Stephens Group increased its AbbVie (ABBV) stake by 2.9% in Q2 2026, buying an estimated $8.82K and bringing the position to 1,456 shares worth $366K. The position accounts for 0.06% of the portfolio, ranked #102.

Helen Stephens Group first reported a position in ABBV in Q3 2024 and has held it in 8 quarters since. The position peaked at $488K in Q3 2025. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Helen Stephens Group held 1,456 shares of AbbVie worth $366K as of Q2 2026.
Helen Stephens Group bought 41 AbbVie shares in Q2 2026, an estimated $8.82K.
AbbVie made up 0.06% of Helen Stephens Group's portfolio in Q2 2026, its #102 holding.
Helen Stephens Group first reported a position in AbbVie in Q3 2024 and has held it in 8 quarters since.
Helen Stephens Group's AbbVie position peaked at $488K in Q3 2025.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Helen Stephens Group's 13F filing for Q2 2026, filed 31 Jul 2026.